ASBP

Aspire Biopharma
ASBP

Overview Fund Trends Analyst Outlook Journalist POV

54 hedge funds and large institutions have $241M invested in Aspire Biopharma in 2022 Q2 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
54
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$21M
2
+$20.4M
3
+$19.6M
4
AA
AQR Arbitrage
Connecticut
+$13.4M
5
HCM
Highbridge Capital Management
New York
+$11.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$21M
2
$20.4M
3
$19.6M
4
$13.4M
5
$11.9M
6
$11.5M
7
$11.5M
8
$11M
9
$8.98M
10
$7.75M
11
$7.36M
12
$6.99M
13
$6.74M
14
$6.69M
15
$6.49M
16
$6.24M
17
$5.99M
18
$4.99M
19
$4.01M
20
$4.01M
21
$3.99M
22
$3.56M
23
$3.49M
24
$3M
25
$2.99M
1
2 3